contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-apoteas-presentation-of-the-year-end-report-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Apotea is active in the e-commerce sector. The company operates as an online pharmacy. The company sells and supplies a wide range of prescription and over-the-counter medicines, skin and hair care products as well as make-up and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and has its headquarters in Stockholm.

Apotea

Apotea AB (publ) (”Apotea”) will publish its year-end report Q4 2025 on Wednesday the 4th of February 2026 at 07:30 am CET. Investors, analysts, media and other interested parties are welcome...

<div class="mfn-preamble"><p><strong>Apotea AB (publ) (”Apotea”) will publish its year-end report Q4 2025 on Wednesday the 4th of February 2026 at 07:30 am CET. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 CET the same day.</strong></p></div><div class="mfn-body"><p>The results for the period January – December 2025 will be presented by Pär Svärdson, CEO, and Johan Mårild, CFO, via a webcast held 4<sup>th</sup> of February 2026 at 09:30 am CET.</p><p>Link for webcast participation (no advance notification is necessary): <a rel="noopener" href="https://apotea.events.inderes.com/q4-report-2025">https://apotea.events.inderes.com/q4-report-2025</a></p><p>If you wish to participate via teleconference, please register on the link below:<br><a rel="noopener" href="https://events.inderes.com/apotea/q4-report-2025/dial-in">https://events.inderes.com/apotea/q4-report-2025/dial-in</a></p><p>The presentation will be held in English.</p></div><div class="mfn-footer mfn-contacts mfn-b12d6662ed35"><p><strong class="mfn-heading-1">Contact</strong><br>Stefan Eriksson, deputy CEO, press &amp; Investor Relations <br>E-mail: ir@apotea.se</p></div><div class="mfn-footer mfn-about mfn-42c70b3e06c2"><p><strong class="mfn-heading-1">About Us</strong><br>Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest<br>pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low<br>prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In<br>E-barometern’s 2024 customer survey, Apotea was ranked as customers’ favourite e-commerce<br>store for the seventh consecutive year. Since 2022, the group also operates in Norway through its<br>Norwegian subsidiary Apotera.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/5525559a-4277-4583-a890-c7fed83861c4/invitation-to-apoteas-presentation-of-the-year-end-report-2025.pdf" class="mfn-generated mfn-primary">Invitation to Apotea’s presentation of the year-end report 2025</a></p></div>

Invitation to Apotea’s presentation of the year-end report 2025

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Solar Foods

Solar Foods is planning a listing on the Nasdaq First North Growth Market Finland marketplace

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation